Selegiline Hydrochloride (Mayne Pharma Inc.)
Welcome to the PulseAid listing for the Selegiline Hydrochloride drug offered from Mayne Pharma Inc.. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mayne Pharma Inc. |
| NON-PROPRIETARY NAME: | Selegiline Hydrochloride |
| SUBSTANCE NAME: | SELEGILINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-05-24 |
| END MARKETING DATE: | 2019-07-31 |
Selegiline Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Selegiline Hydrochloride from Mayne Pharma Inc. |
| LABELER NAME: | Mayne Pharma Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2014-05-24 |
| END MARKETING DATE: | 2019-07-31 |
| PRODUCT ID: | 51862-146_2a690da9-9323-4703-9364-4065edd936a6 |
| PRODUCT NDC: | 51862-146 |
| APPLICATION NUMBER: | ANDA074912 |
Other SELEGILINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
